Latest Biotechnology News and Updates : Biotechnology updates, Biotechnology News , Biotechnology around the world

Nishadil

Washington | 31°C (broken clouds)

A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition

Top story

A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition

In focus

Latest feed

Myqorzo Shines: Cytokinetics' Aficamten Delivers Hope for Non-Obstructive HCM Patients

Alnylam's Heart-Stopping Ambition: Reshaping Cardiovascular Care at ESC

Krystal Biotech Shines Bright: RBC Capital Markets Sees Major Upside

FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment

Latest headlines

A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus

A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus

Elicio Therapeutics Navigates Q2 2026 with Strong Financing and Promising Clinical Signals

Elicio Therapeutics Navigates Q2 2026 with Strong Financing and Promising Clinical Signals

Elicio Therapeutics Marks Significant Financial Turnaround and Pivotal Clinical Advances in Latest Quarter

Elicio Therapeutics Marks Significant Financial Turnaround and Pivotal Clinical Advances in Latest Quarter

After-Hours Jitters: Why AMAT, DLO, and ZNTL Saw Dips Despite a Bullish Market Day

After-Hours Jitters: Why AMAT, DLO, and ZNTL Saw Dips Despite a Bullish Market Day

A Revolutionary Shield: Unlocking Snakebite Antidotes from Venomous Blood Itself

A Revolutionary Shield: Unlocking Snakebite Antidotes from Venomous Blood Itself

A Glimmer of Hope: New Alzheimer's Drug Shows Remarkable Safety in Early Trial

A Glimmer of Hope: New Alzheimer's Drug Shows Remarkable Safety in Early Trial

The No Surprises Act's Unintended Consequence: A Multi-Billion Dollar Headache for Healthcare

The No Surprises Act's Unintended Consequence: A Multi-Billion Dollar Headache for Healthcare

India’s Experts Call for an Overhaul of GM & Genome‑Edited Crop Regulations

India’s Experts Call for an Overhaul of GM & Genome‑Edited Crop Regulations

Rare‑Disease Biotechs Push Back on Trump’s Price‑Cut Push While PBMs Slip Around State Laws

Rare‑Disease Biotechs Push Back on Trump’s Price‑Cut Push While PBMs Slip Around State Laws

Rare Disease Makers Push Back on Medicare Price‑Cut Pilots

Rare Disease Makers Push Back on Medicare Price‑Cut Pilots

Rare‑Disease Makers Push for Medicare Price‑Cut Exemptions

Rare‑Disease Makers Push for Medicare Price‑Cut Exemptions

CRISPR Therapeutics: On the Cusp of a New Era in Medicine

CRISPR Therapeutics: On the Cusp of a New Era in Medicine

Most-Wanted Fugitive Turns Out to Be a Biotech C‑Level Executive

Most-Wanted Fugitive Turns Out to Be a Biotech C‑Level Executive

A Glimmer of Hope: ARTIDIS Kicks Off Groundbreaking OPTIMAL-E Trial for Prostate Cancer

A Glimmer of Hope: ARTIDIS Kicks Off Groundbreaking OPTIMAL-E Trial for Prostate Cancer

A New Chapter in Prostate Cancer Care: First Patients Dosed in Pivotal OPTIMAL-E Trial

A New Chapter in Prostate Cancer Care: First Patients Dosed in Pivotal OPTIMAL-E Trial

Daraxonrasib and the Fight Against Pancreatic Cancer: Hope Meets Hurdles

Daraxonrasib and the Fight Against Pancreatic Cancer: Hope Meets Hurdles

Daroxanrasib and Pancreatic Cancer: A New Hope Amidst Ongoing Hurdles

Daroxanrasib and Pancreatic Cancer: A New Hope Amidst Ongoing Hurdles

Alzheimer's Research: A New Frontier Unlocked at AAIC

Alzheimer's Research: A New Frontier Unlocked at AAIC

The Shifting Sands of Alzheimer's Research: Why Tau and the Blood-Brain Barrier Are Our New Front Lines

The Shifting Sands of Alzheimer's Research: Why Tau and the Blood-Brain Barrier Are Our New Front Lines

Navigating the Biotech Boom: Uncovering Breakthrough Opportunities While Guarding Against Cash Burn

Navigating the Biotech Boom: Uncovering Breakthrough Opportunities While Guarding Against Cash Burn

Hong Kong Gears Up to Host Global Biotechnology Leaders at BIOHK2026

Hong Kong Gears Up to Host Global Biotechnology Leaders at BIOHK2026

Get Ready for BIOHK2026: Hong Kong Set to Spark Global Biotech Innovation

Get Ready for BIOHK2026: Hong Kong Set to Spark Global Biotech Innovation

Scientists Just Unveiled the Most Lifelike Synthetic Cell Yet: A Glimpse into the Future of Biology

Scientists Just Unveiled the Most Lifelike Synthetic Cell Yet: A Glimpse into the Future of Biology

DxVx Takes Center Stage at BIO USA, Forging Global Alliances for Breakthrough Therapies

DxVx Takes Center Stage at BIO USA, Forging Global Alliances for Breakthrough Therapies

The AI Revolution in Biotech: Anthropic's Impact on Our Health Future

The AI Revolution in Biotech: Anthropic's Impact on Our Health Future

A Smarter Scissors: New CRISPR-Like Tool Promises Safer, More Precise Gene Editing

A Smarter Scissors: New CRISPR-Like Tool Promises Safer, More Precise Gene Editing

A Breakthrough for Gene Editing: Unlocking CRISPR's Full Potential

A Breakthrough for Gene Editing: Unlocking CRISPR's Full Potential

The Capitol's Pulse: When Wellness Met Wealth, and Big Pharma Prevailed

The Capitol's Pulse: When Wellness Met Wealth, and Big Pharma Prevailed

A New Dawn: Roche's Landmark Drug Redefines Hope for KRAS-Driven Lung Cancer Patients

A New Dawn: Roche's Landmark Drug Redefines Hope for KRAS-Driven Lung Cancer Patients

Arcturus Therapeutics Charts a Bold New Course with Thermo Fisher Alliance

Arcturus Therapeutics Charts a Bold New Course with Thermo Fisher Alliance

Abivax’s Obefazimod Shows Promising Safety in Late‑Stage Ulcerative Colitis Maintenance Study

Abivax’s Obefazimod Shows Promising Safety in Late‑Stage Ulcerative Colitis Maintenance Study

The GLP-1 Revolution: A Budgetary Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Budgetary Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Financial Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Financial Tightrope for Medicare and Medicaid

Bird‑Inspired Gene‑Editing Breakthrough Promises Safer DNA Insertion

Bird‑Inspired Gene‑Editing Breakthrough Promises Safer DNA Insertion

From Field to Future: How Biotechnology and New Business Models Could Rewrite Our Food System

From Field to Future: How Biotechnology and New Business Models Could Rewrite Our Food System

From Field to Future: Biotech and Business Models Rethink Our Food System

From Field to Future: Biotech and Business Models Rethink Our Food System

AbbVie Takes the Leap: Why the $2.5 B Buy‑out of Apogee Therapeutics Could Redefine Immunology

AbbVie Takes the Leap: Why the $2.5 B Buy‑out of Apogee Therapeutics Could Redefine Immunology

Pharma & Biotech M&A Surge Hits $123 Billion in 2026

Pharma & Biotech M&A Surge Hits $123 Billion in 2026

Load more